|
Special Report - Health Care - June 21, 2012 |
Newswise
A growing concern with fraud and misconduct in published drug studies has led researchers at the University of Illinois at Chicago's Center for Pharmacoeconomic Research to investigate the extent and reasons for retractions in the research.
"We were surprised to find the proportion of retractions due to scientific misconduct in the drug literature is higher than in general biomedical literature," says Simon Pickard, associate professor of pharmacy practice and senior author of a st...
If you are a subscriber or have purchased this article, please login to view this article in it's entirety.
"We were surprised to find the proportion of retractions due to scientific misconduct in the drug literature is higher than in general biomedical literature," says Simon Pickard, associate professor of pharmacy practice and senior author of a st...
Article Options:
Purchase Full Article - $1.50 | Subscribe Online | Current Subscribers: Login
If you are a subscriber or have purchased this article, please login to view this article in it's entirety.
Subscribers have access to articles up to one year old. Purchased articles can be accessed in your account for 30 days.



